U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07229820) titled 'Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A' on Nov. 13.
Brief Summary: This trial is conducted in China. This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of ZSP1273 in the treatment of Acute Uncomplicated influenza A in adolescents.
Study Start Date: Nov. 30
Study Type: INTERVENTIONAL
Condition:
Influenza A
Intervention:
DRUG: ZSP1273
Oral
DRUG: Placebo
Oral
Recruitment Status: RECRUITING
Sponsor: Guangdong Raynovent Biotech Co., Ltd
Disclaimer: Curated by HT Syndication....